+1 888-880-9539Search News by Tag: hyperCORE International
11 news stories found
Press Release
April 23, 2026
The Central Florida-based clinical research organization brings decades of experience, strong enrollment, and community-centered research to hyperCORE's expanding global network
Read Press Release
Press Release
March 10, 2026
The growing multi-state research organization brings expanded therapeutic expertise and patient access to hyperCORE's collaborative global network
Read Press Release
Press Release
September 29, 2025
Jeffrey Smyth of TrueBlue Clinical Research and Olivia McIver of Applied Research Center join hyperCORE's executive team, strengthening governance and supporting sustainable growth across its partner site networks.
Read Press Release
Press Release
August 5, 2025
Epic expands hyperCORE's U.S. footprint with multi-state capabilities, advanced Phase I infrastructure, and deep expertise across high-demand therapeutic areas
Read Press Release
Press Release
July 29, 2025
Longtime Member and FOMAT CEO Nicholas Focil Appointed to Lead Global Research Site Network
Read Press Release
Press Release
August 8, 2024
Alberta's CaRe Clinic Joins hyperCORE International's Clinical Research Network
Read Press Release
Press Release
May 29, 2024
ARC brings 10 years of high-quality, multi-specialty research to the clinical trial super network
Read Press Release
Press Release
February 11, 2024
Gwen Welty joins the clinical research super network as Executive Director and Karri Venn as Executive Consultant
Read Press Release
Press Release
September 29, 2023
Emerson brings a broad range of expertise in equitable health access to the clinical trial super network
Read Press Release
Press Release
September 8, 2023
Industry veteran Christine Obercian will serve as Executive Director
for the clinical trial site super network.
Read Press Release
Press Release
March 24, 2021
Columbus-based clinical research company collaborates with super network to advance the efficiency of its clinical trials and expand expertise across vaccine, internal medicine, dermatology, and many additional therapeutic areas.
Read Press Release